SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signalling

Endocrine-Related Cancer

Volumn 17, Issue 4, 2010, Pages 919-928

  Blank, Annika ^a,d   Schmitt, Anja M ^d   Korpershoek, Esther ^b   Van Nederveen, Francien ^b   Rudolph, Thomas ^d   Weber, Nicole ^c   Strebel, Räto Thomas ^c   De Krijger, Ronald ^b   Komminoth, Paul ^e   Perren, Aurel ^a,d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e TRIEMLI HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE SUBUNIT B; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; MALE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PREDICTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYMPATHETIC PARAGANGLIOMA;

ADRENAL GLAND NEOPLASMS; CELL HYPOXIA; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA; FEMALE; GERM-LINE MUTATION; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES; SUCCINATE DEHYDROGENASE;

EID: 78649875568     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0316     Document Type: Article

References (36)

1. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A et al. 2005 Genetic testing in pheochromocytoma or functional paraganglioma. Journal of Clinical Oncology 23 8812-8818. (doi:10.1200/JCO.2005.03. 1484)
2. August C, August K, Schroeder S, Bahn H, Hinze R, Baba HA, Kersting C & Buerger H 2004 CGH and CD 44/MIB- 1 immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas. Modern Pathology 17 1119-1128. (doi:10.1038/modpathol.3800160)
3. Bishop T, Lau KW, Epstein AC, Kim SK, Jiang M, O'Rourke D, Pugh CW, Gleadle JM, Taylor MS, Hodgkin J et al. 2004 Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans. PLoS Biology 2 e289. (doi:10.1371/journal.pbio.0020289)
4. Bubendorf L, Nocito A, Moch H & Sauter G 2001 Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. Journal of Pathology 195 72-79. (doi:10.1002/path.893)
5. Couvelard A, O'Toole D, Turley H, Leek R, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter K et al. 2005 Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. British Journal of Cancer 92 94-101. (doi:10.1038/sj.bjc.6602245)
6. Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS et al. 2005 A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genetics 1 72-80. (doi:10.1371/journal.pgen.0010008)
7. Eisenhofer G, Huynh TT, Pacak K, Brouwers FM, Walther MM, Linehan WM, Munson PJ, Mannelli M, Goldstein DS & Elkahloun AG 2004 Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel - Lindau syndrome. Endocrine-Related Cancer 11 897-911. (doi:10.1677/erc.1.00838)
8. Favier J, Briere JJ, Burnichon N, Riviere J, Vescovo L, Benit P, Giscos-Douriez I, De Reynies A, Bertherat J, Badoual C et al. 2009 The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS ONE 4 e7094. (doi:10.1371/journal.pone.0007094)
9. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Kerlan V, Plouin PF, Rotig A & Jeunemaitre X 2002 Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 87 4771-4774. (doi:10.1210/jc.2002-020525)
10. van der Harst E, Bruining HA, Jaap Bonjer H, van der Ham F, Dinjens WN, Lamberts SW, de Herder WW, Koper JW, Stijnen T, Proye C et al. 2000 Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases? Journal of Pathology 191 175-180. (doi:10. 1002/(SICI)1096- 9896(200006)191:2〈175::AIDPATH615〉3.0. CO;2-Z)
11. Hergovich A, Lisztwan J, Barry R, Ballschmieter P & Krek W 2003 Regulation of microtubule stability by the von Hippel - Lindau tumour suppressor protein pVHL. Nature Cell Biology 5 64-70. (doi:10.1038/ncb899)
12. Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M & Kaelin WG Jr 2001 von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Human Molecular Genetics 10 1019-1027. (doi:10. 1093/hmg/10.10.1019)
13. Kaelin WG Jr 2004 The von Hippel - Lindau tumor suppressor gene and kidney cancer. Clinical Cancer Research 10 6290S-6295S. (doi:10.1158/1078-0432. CCR-sup-040025)
14. Karagiannis A, Mikhailidis DP, Athyros VG & Harsoulis F 2007 Pheochromocytoma: an update on genetics and management. Endocrine-Related Cancer 14 935-956. (doi:10.1677/ERC-07-0142)
15. Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ & Van Meir EG 2005 Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro-Oncology 7 134-153. (doi:10.1215/S1152851704001115)
16. Kimura N, Watanabe T, Noshiro T, Shizawa S & Miura Y 2005 Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocrine Pathology 16 23-32. (doi:10.1385/EP:16:1:023)
17. Komminoth P, Perren A, van Nederveen FH & Krijger RR 2009 Familial endocrine tumours: phaeochromocytomas and extra-adrenal paragangliomas. Diagnostic Histopathology 15 61-68. (doi:10.1016/j.mpdhp.2009.01.003)
18. Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP, Farese RV, Freeman RS, Carter BD, Kaelin WG Jr et al. 2005 Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8 155-167. (doi:10.1016/j.ccr.2005.06.015)
19. Lenders JW, Eisenhofer G, Mannelli M & Pacak K 2005 Phaeochromocytoma. Lancet 366 665-675. (doi:10.1016/S0140-6736(05)67139-5)
20. Maier-Woelfle M, Brandle M, Komminoth P, Saremaslani P, Schmid S, Locher T, Heitz PU, Krull I, Galeazzi RL, Schmid C et al. 2004 A novel succinate dehydrogenase subunit B gene mutation, H132P, causes familial malignant sympathetic extraadrenal paragangliomas. Journal of Clinical Endocrinology and Metabolism 89 362-367. (doi:10.1210/jc.2003-031236)
21. Maxwell PH 2005 A common pathway for genetic events leading to pheochromocytoma. Cancer Cell 8 91-93. (doi:10.1016/j.ccr.2005.07.012)
22. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER & Ratcliffe PJ 1999 The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 271-275. (doi:10.1038/20459)
23. McWhinney SR, Pilarski RT, Forrester SR, Schneider MC, Sarquis MM, Dias EP & Eng C 2004 Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. Journal of Clinical Endocrinology and Metabolism 89 5694-5699. (doi:10. 1210/jc.2004-0769)
24. van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, Sleddens HF, Derkx P, Riviere J, Dannenberg H et al. 2009 An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncology 10 764-771. (doi:10.1016/S1470-2045(09)70164-0)
25. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K et al. 2002 Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine 346 1459-1466. (doi:10.1056/NEJMoa020152)
26. Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, Hunt T, Jeffery R, Seedhar P, Barwell J et al. 2006 Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. Journal of Clinical Endocrinology and Metabolism 91 4593-4598. (doi:10.1210/jc.2006-0920)
27. Qing G & Simon MC 2009 Hypoxia inducible factor-2alpha: a critical mediator of aggressive tumor phenotypes. Current Opinion in Genetics & Development 19 60-66. (doi:10.1016/j.gde.2008.12.001)
28. Schmitt AM, Schmid S, Rudolph T, Anlauf M, Prinz C, Kloppel G, Moch H, Heitz PU, Komminoth P & Perren A 2009 VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors. Endocrine-Related Cancer 16 1219-1227. (doi:10.1677/ERC-08-0297)
29. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB & Gottlieb E 2005 Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7 77-85. (doi:10.1016/j. ccr.2004.11.022)
30. Selak MA, Duran RV & Gottlieb E 2006 Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells. Biochimica et Biophysica Acta 1757 567-572. (doi:10.1016/j.bbabio. 2006.05.015)
31. Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, Fong Y, Brennan M & Ghossein RA 2008 Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery 143 759-768. (doi:10.1016/j.surg.2008.02.007)
32. Thompson LD 2002 Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. American Journal of Surgical Pathology 26 551-566. (doi:10.1097/00000478-200205000-00002)
33. Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JW & Pacak K 2007 Clinical presentations, biochemical phenotypes, and genotype - phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. Journal of Clinical Endocrinology and Metabolism 92 779-786. (doi:10.1210/jc.2006-2315) (Pubitemid 46465640)
34. Tischler AS 2008 Pheochromocytoma and extra-adrenal paraganglioma: updates. Archives of Pathology & Laboratory Medicine 132 1272-1284.
35. van Uden P, Kenneth NS & Rocha S 2008 Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochemical Journal 412 477-484. (doi:10.1042/BJ20080476)
36. Wu D, Tischler AS, Lloyd RV, DeLellis RA, de Krijger R, van Nederveen F & Nose V 2009 Observer variation in the application of the pheochromocytoma of the adrenal gland scaled score. American Journal of Surgical Pathology 33 599-608. (doi:10.1097/PAS.0b013e318190d12e)